Biochemist, Ph.D., MBA, with over 15 years of experience as a Life Science and healthcare professionals working in an international environment with matters related to scientific research, business development, technology transfer, regulation, internationalization, and financing.
Currently employed as an Investment Advisor for Life Science at Business Region Göteborg, Iris provides advice and support to key executives from international investment firms and Fortune 500 companies looking for novel breakthrough technologies that could impact or disrupt the market.
Iris Öhrn is currently involved in several European organizations either as an expert or as a member of the board. For instance, she is the Vice Chairman of ScanBalt, a Healthtech mega-region in the Nordics and Baltics. She is one of the experts and jury members of the European Commission / EASME investment committee that selects and funds with 3Beur Europe’s most disruptive SMEs. Iris Öhrn is also in the Health Committee of EBAN, the European Business Angels network and part of one of OECD’s Innovation and Technology Committees.